[1]
M. I. Passalacqua, A. Squeri, C. Sciumè, A. Ieni, and M. Santarpia, “Enfortumab Vedotin in metastatic bladder cancer: a case report of durable clinical efficacy in a pretreated patient”, Acta Biomed, vol. 94, no. S1, p. e2023070, Mar. 2023, doi: 10.23750/abm.v94iS1.14114.